BofA analyst Joanna Gajuk downgraded Ardent Health (ARDT) to Underperform from Neutral with a price target of $14.60, down from $15.50. The firm downgraded four healthcare facility and managed care stocks that it believes are most exposed to the One Big Beautiful Bill. The bill has a board range of negative implications and creates downside risk to growth estimates for the sector, the analyst tells investors in a research note. The subsidy cuts to Medicaid and Affordable Care Act exchanges are not reflected in consensus estimates and for many companies not reflected in stock prices, contends BofA.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDT:
- Ardent Health downgraded to Underperform from Neutral at BofA
- Buy Rating for Ardent Health Partners, Inc. Amid Strong Sector Trends and Discounted Valuation
- Ardent Health Announces Departure of Hospital Operations President
- Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating
- RBC a buyer of hospital stocks on White House memo selloff